|
Tuesday, 19 May 2009 17:55 |
|
A novel vaccine strategy using virus-like particles (VLPs) could provide stronger and longer-lasting influenza vaccines with a significantly shorter development and production time than current ones, allowing public health authorities to react more quickly in the event of a potential pandemic. |
|
Read more...
|
|
Wednesday, 13 May 2009 16:45 |
A team of Princeton University scientists may have found a better way to make a vaccine against the flu virus.
Though theoretical, the work points to the critical importance of what has been a poorly appreciated aspect of the interaction between a virus and those naturally produced defensive proteins called antibodies that fight infection. By manipulating this multi-stage interactive process - known as antibody interference - to advantage, the scientists believe it may be possible to design more powerful vaccines than exist today. |
|
Read more...
|
|
Monday, 11 May 2009 16:31 |
The first step towards producing a European prototype of a swine flu vaccine has been achieved by the Health Protection Agency (HPA), Health Secretary Alan Johnson has announced. On a visit to the HPA's National Institute of Biological Standards and Control (NIBSC) this morning, Alan Johnson learnt that researchers have sequenced the full genetic code of the virus. This is critical in understanding how the virus operates and identifying the crucial parts of the virus that can be used in vaccine manufacture.
|
|
Read more...
|
|
Friday, 08 May 2009 16:39 |
|
Swine flu will be high on the agenda of the ILSI-Biomed exhibition in Israel this June, as local and international companies developing universal flu vaccines and vaccine delivery methods exhibit their new products there. "It is crucial that Biomed Israel, as a leading life science conference, consistently feature issues having the greatest impact on the world," said Ruti Alon, ILSI Chairperson. |
|
Read more...
|
|
Thursday, 07 May 2009 08:37 |
 Should global vaccine production be required, then 1 to 2 billion doses could be made to combat the new H1N1 flu virus, said officials from the World Health Organization (WHO) on Wednesday, just before the global health agency released the latest count of 1,893 confirmed cases in 23 countries and 31 deaths (29 in Mexico and two in the US). |
|
Read more...
|
|
Wednesday, 06 May 2009 16:38 |
|
World Health Organization experts will meet next week to consider whether drug makers should switch from seasonal to pandemic flu production in response to the new H1N1 strain, an official said Wednesday. |
|
Read more...
|
|
Monday, 04 May 2009 16:23 |
|
The European Medicines Agency, together with its partners in the EU Member States, the European Commission, the European Centre for Disease Prevention and Control (ECDC), the World Health Organization (WHO) and the European Directorate for the Quality of medicines and healthcare (EDQM) met today with vaccine manufacturers. |
|
Read more...
|
|
Friday, 01 May 2009 19:32 |
 New research published April 27 from the University of Leicester and University Hospitals of Leicester NHS Trust warns of a six-month time lag before effective vaccines can be manufactured in the event of a pandemic flu outbreak. |
|
Read more...
|
|
Thursday, 30 April 2009 13:50 |
|
 Europe's drugs watchdog met vaccine manufacturers on Thursday, a further step in preparations for a flu pandemic.
|
|
Read more...
|
|
|
Friday, 15 May 2009 15:59 |
|
GlaxoSmithKline said on Friday several European governments had ordered stockpiles of a pandemic vaccine the British drugmaker is developing against the new H1N1 flu virus. |
|
Read more...
|
|
Tuesday, 12 May 2009 15:39 |
|
BDI Pharma, Inc. (BDI), the nation's preeminent distributor of specialty biopharmaceuticals, announced today the unveiling of SecuriFLU, a new online supply solution where customers may pre-book orders for the upcoming flu season, as well as place orders for this year's current strain. The website also serves to provide education on the impending influenza season along with CDC recommendations and updates on the H1N1 (Swine Flu) virus. |
|
Read more...
|
|
Monday, 11 May 2009 16:26 |
|
A study published this week in the Proceedings of the National Academy of Sciences of the United States of America shows that Aflunov®, the Novartis investigational pre-pandemic avian influenza vaccine formulated with Novartis' proprietary MF59® adjuvant, can elicit a broadly cross-reactive immune response covering all known H5N1 antigenic variants, even when that booster dose is administered six years after the initial priming dose. |
|
Read more...
|
|
Thursday, 07 May 2009 16:31 |
|
A strain-specific vaccine for the H1N1 flu virus, also known as the swine flu, that potentially could be developed by researchers might not be as beneficial as some might hope because uninsured U.S. residents are unlikely to purchase the vaccine, the AP/Miami Herald reports. |
|
Read more...
|
|
Thursday, 07 May 2009 08:08 |
|
FDA approved Sanofi Pasteur's new manufacturing facility for the production of seasonal influenza vaccine. It could also be used for the manufacture of a vaccine against the new 2009 H1N1 influenza strain, or swine flu. |
|
Read more...
|
|
Tuesday, 05 May 2009 16:32 |
|
Virginia Tech virologist Chris Roberts' goal is to develop a platform for a flu vaccine that allows rapid modifications to meet new strains of flu. |
|
Read more...
|
|
Monday, 04 May 2009 16:19 |
|
As the world confronts a possible swine flu pandemic, a new poll by The Harris Poll underlines the difficulty scientists have in developing effective flu vaccines. This poll finds that 18% of all adults believe they had the flu last winter. |
|
Read more...
|
|
Thursday, 30 April 2009 14:16 |
|
 The U.N. World Health Organization and U.S. Centers for Disease Control and Prevention have been collecting samples of the new H1N1 swine flu virus to make a new vaccine in case it is needed.
|
|
Read more...
|
|
